TY - JOUR
T1 - Smoking-Cessation Interventions for Urban Hospital Patients
T2 - A Randomized Comparative Effectiveness Trial
AU - Sherman, Scott E.
AU - Link, Alissa R.
AU - Rogers, Erin S.
AU - Krebs, Paul
AU - Ladapo, Joseph A.
AU - Shelley, Donna R.
AU - Fang, Yixin
AU - Wang, Binhuan
AU - Grossman, Ellie
N1 - Funding Information:
The Consortium of Hospitals Advancing Research on Tobacco was funded by NHLBI, the National Cancer Institute, the National Institute on Drug Abuse, and the Office of Behavioral and Social Sciences by cooperative agreements to a research coordinating unit (Kaiser Foundation Research Institute, Principal Investigator [PI]: Victor Stevens, PhD, U01HL52333) and six research projects (New York University School of Medicine, PI: Scott Sherman, MD, U01HL105229; University of California San Diego, PI: Shu-Hong Zhu, U01CA159533; University of Kansas Medical Center, PI: Kimber Richter, PhD, U01HL105232; University of Alabama Birmingham, PI: Kathleen Harrington, PhD, MPH, U01DA031515; University of Michigan Ann Arbor, PI: Sonia Duffy, PhD, U01HL105218; Kaiser Foundation Research Institute, PI: Jeffrey Fellows, PhD, U01HL105231). An additional project (Massachusetts General Hospital, PI: Nancy Rigotti, MD, RC1HL099668) has been included in the consortium. NIH Project Scientists on this project have included Lawton Cooper, MD, Sarah Duffy, PhD, Debra Grossman, PhD, Glen Morgan, PhD, William Riley, PhD, Catherine Stoney, PhD, and Xin Tian, PhD.
Funding Information:
This work was supported by a grant from the National Heart, Lung and Blood Institute (NHLBI) of NIH (#1U01HL105229) and a Hurricane Sandy Supplement (#3U01HL105229-04S1), and also in part by the New York University Clinical and Translational Science Award grant UL1TR000038 from the National Center for Advancing Translational Sciences, NIH. Dr. Sherman is also supported by a grant from the National Institute on Drug Abuse (#1K24DA038345) and by the VA New York Harbor Healthcare System.
Publisher Copyright:
© 2016
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Introduction Hospitalization is a unique opportunity for smoking cessation, but prior interventions have measured efficacy with narrowly defined populations. The objective of this study was to enroll smokers admitted to two “safety net” hospitals and compare the effectiveness of two post-discharge cessation interventions. Design A randomized comparative effectiveness trial was conducted. Setting/participants At two New York City public hospitals, every hospitalized patient identified as a smoker (based on admission records) was approached. Inclusion criteria were: smoked cigarettes in the past 30 days; spoke English, Spanish, or Mandarin; had a U.S. phone number; not discharged to an institution where follow-up or smoking was limited; and not pregnant/breastfeeding. Of 18,797 patients identified as current smokers between July 2011 and April 2014, a total of 3,047 (16%) were discharged before being approached, 3,273 (17%) were not current smokers, 4,026 (21%) had no U.S. phone number, 2,831 (15%) were ineligible for other reasons, and 3,983 (21%) refused participation. In total, 1,618 (9%) participants enrolled in the study. During follow-up, 69% of participants were reached at 2 months and 68% at 6 months. Intervention At discharge, participants were randomized to multisession telephone counseling from study staff (n=804) or referral to the state quitline for proactive outreach and counseling (n=814). Main outcome measures Self-reported abstinence at 6 months was measured. Analyses were conducted in late 2015. Results One quarter of participants were homeless or in unstable housing, 60% had a history of substance abuse, 43% reported current hazardous drinking, and half had a psychiatric diagnosis other than substance abuse. At follow-up, the rate of abstinence (30-day point prevalence) was higher in the intensive counseling arm than the quitline arm at 2 months (29.0% vs 20.7%; relative risk=1.40; 95% CI=1.13, 1.73) and 6 months (37.4% vs 31.5%; relative risk=1.19; 95% CI=1.01, 1.40). Conclusions Intensive counseling was more effective than referral to the state quitline. Long-term abstinence was excellent in both groups. Many patients were not eligible for enrollment despite minimal exclusion criteria. Trial Registration This study is registered at www.clinicaltrials.gov NCT01363245.
AB - Introduction Hospitalization is a unique opportunity for smoking cessation, but prior interventions have measured efficacy with narrowly defined populations. The objective of this study was to enroll smokers admitted to two “safety net” hospitals and compare the effectiveness of two post-discharge cessation interventions. Design A randomized comparative effectiveness trial was conducted. Setting/participants At two New York City public hospitals, every hospitalized patient identified as a smoker (based on admission records) was approached. Inclusion criteria were: smoked cigarettes in the past 30 days; spoke English, Spanish, or Mandarin; had a U.S. phone number; not discharged to an institution where follow-up or smoking was limited; and not pregnant/breastfeeding. Of 18,797 patients identified as current smokers between July 2011 and April 2014, a total of 3,047 (16%) were discharged before being approached, 3,273 (17%) were not current smokers, 4,026 (21%) had no U.S. phone number, 2,831 (15%) were ineligible for other reasons, and 3,983 (21%) refused participation. In total, 1,618 (9%) participants enrolled in the study. During follow-up, 69% of participants were reached at 2 months and 68% at 6 months. Intervention At discharge, participants were randomized to multisession telephone counseling from study staff (n=804) or referral to the state quitline for proactive outreach and counseling (n=814). Main outcome measures Self-reported abstinence at 6 months was measured. Analyses were conducted in late 2015. Results One quarter of participants were homeless or in unstable housing, 60% had a history of substance abuse, 43% reported current hazardous drinking, and half had a psychiatric diagnosis other than substance abuse. At follow-up, the rate of abstinence (30-day point prevalence) was higher in the intensive counseling arm than the quitline arm at 2 months (29.0% vs 20.7%; relative risk=1.40; 95% CI=1.13, 1.73) and 6 months (37.4% vs 31.5%; relative risk=1.19; 95% CI=1.01, 1.40). Conclusions Intensive counseling was more effective than referral to the state quitline. Long-term abstinence was excellent in both groups. Many patients were not eligible for enrollment despite minimal exclusion criteria. Trial Registration This study is registered at www.clinicaltrials.gov NCT01363245.
UR - http://www.scopus.com/inward/record.url?scp=84991833372&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84991833372&partnerID=8YFLogxK
U2 - 10.1016/j.amepre.2016.06.023
DO - 10.1016/j.amepre.2016.06.023
M3 - Article
C2 - 27647057
AN - SCOPUS:84991833372
SN - 0749-3797
VL - 51
SP - 566
EP - 577
JO - American journal of preventive medicine
JF - American journal of preventive medicine
IS - 4
ER -